BB
Healthcare & Life Sciences
Belhaven Biopharma
United Statesbelhavenbio.com
Belhaven Biopharma is a Healthcare & Life Sciences startup based in the United States, most recent round Series A, 1 tracked investor.
series-a
series-a
Stage
1
Investors
About Belhaven Biopharma
Belhaven Biopharma is a company headquartered in the United States. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Belhaven Biopharma is developing Nasdepi®, a dry powder, needle-free epinephrine nasal spray designed for rapid treatment of severe allergic reactions and anaphylaxis, aiming to improve accessibility and ease of use worldwide.
Explore Belhaven Biopharma's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.